Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast Cancer

Detection of circulating tumor cells (CTC) can distinguish between aggressive and indolent metastatic disease in breast cancer patients and is thus considered an independent, negative prognostic factor. A clear decline in CTCs is observed in patients who respond to systemic therapy. Nevertheless, CT...

Descripción completa

Detalles Bibliográficos
Autores principales: Deutsch, Thomas M., Stefanovic, Stefan, Feisst, Manuel, Fischer, Chiara, Riedel, Fabian, Fremd, Carlo, Domschke, Christoph, Pantel, Klaus, Hartkopf, Andreas D., Sutterlin, Marc, Brucker, Sara Y., Schneeweiss, Andreas, Wallwiener, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226373/
https://www.ncbi.nlm.nih.gov/pubmed/32344685
http://dx.doi.org/10.3390/cancers12041055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226373/
https://www.ncbi.nlm.nih.gov/pubmed/32344685
http://dx.doi.org/10.3390/cancers12041055

Ejemplares similares